BioMarin Pharmaceutical
BMRN
#1910
Rank
C$14.18 B
Marketcap
C$73.84
Share price
-0.19%
Change (1 day)
-21.88%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Total debt

Total debt on the balance sheet as of September 2025 : C$0.83 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's total debt is C$0.83 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioMarin Pharmaceutical - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$0.86 B-40.49%
2023-12-31C$1.45 B-2.04%
2022-12-31C$1.48 B6.85%
2021-12-31C$1.38 B0.19%
2020-12-31C$1.38 B23.55%
2019-12-31C$1.12 B-0.84%
2018-12-31C$1.13 B-23.39%
2017-12-31C$1.47 B60.82%
2016-12-31C$0.91 B-0.06%
2015-12-31C$0.91 B23.14%
2014-12-31C$0.74 B6.91%
2013-12-31C$0.69 B101.53%
2012-12-31C$0.34 B-2.27%
2011-12-31C$0.35 B-6.11%
2010-12-31C$0.37 B-27.85%
2009-12-31C$0.52 B-24.24%
2008-12-31C$0.69 B39.15%
2007-12-31C$0.49 B84.7%
2006-12-31C$0.26 B2.89%
2005-12-31C$0.26 B-19.74%
2004-12-31C$0.32 B100.62%
2003-12-31C$0.16 B
2001-12-31C$8.84 M7012.64%
2000-12-31C$0.12 M-22.33%
1999-12-31C$0.16 M4.13%
1998-12-31C$0.15 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Ultragenyx Pharmaceutical
RARE
C$46.86 M-94.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$35.21 M-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$0.42 B-49.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$35.36 B 4,125.35%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
C$0.61 B-26.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$4 M-99.52%๐Ÿ‡บ๐Ÿ‡ธ USA